• Please log in or register to access this feature.

Special Article

You have free access to this content

Family Coronary Heart Disease: A Call to Action

  1. H. Robert Superko MD, FACC1,2,4,*,
  2. Robert Roberts MD, MACC3,
  3. Brenda Garrett RN1,2,
  4. Lakshmana Pendyala MD1,
  5. Spencer King III MD, MACC1

Article first published online: 23 DEC 2010

DOI: 10.1002/clc.20684

Issue

Clinical Cardiology

Clinical Cardiology

Volume 33, Issue 12, pages E1–E6, December 2010

Additional Information

How to Cite

Superko, H. R., Roberts, R., Garrett, B., Pendyala, L. and King III, S. (2010), Family Coronary Heart Disease: A Call to Action. Clin Cardiol, 33: E1–E6. doi: 10.1002/clc.20684

Author Information

  1. 1

    Center for Genomics and Human Health, Saint Joseph's Translational Research Institute, Atlanta, Georgia

  2. 2

    Cholesterol, Genetics, and Heart Disease Institute, Portola Valley, California

  3. 3

    University of Ottawa Heart Institute, Ottawa, Canada

  4. 4

    Celera, Chief of Medical Affairs, Alameda, California

*Celera Corporation, 1401 Harbor Bay Parkway, Alameda, California 94502.

Publication History

  1. Issue published online: 23 DEC 2010
  2. Article first published online: 23 DEC 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (129K)

REFERENCES

  • 1
    Böhm M, Werner C, Jakobsen A, et al. Treating to protect: current cardiovascular treatment approaches and remaining needs. Medscape J Med 2008; 10(Suppl): S3.
  • 2
    NCEP ATP-III. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.
  • 3
    Friedlander Y. Genetic Factors in Coronary Heart Disease. Hingham, MA: Kluwer Academic Publishers; 1994.
  • 4
    Berg K. Impact of medical genetics on research and practices in the area of cardiovascular disease. Clin Genet 1989; 36: 299–312.
  • 5
    McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488–1491.
  • 6
    Wade N. Experts advise a grain of salt with mail-order genomes, at $1,000 a pop. New York Times. Published: November 17, 2007. www.nytimes.com/2007/11/17/us/17genome.html.
  • 7
    Goldstein JL, Schrott HG, Hazzard WR, et al. Hyperlipidemia in coronary heart disease II. genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544–1568.
  • 8
    Cirino AL, Ho CY. Genetic testing in cardiac disease: from bench to bedside. Nat Clin Pract Cardiovasc Med 2006; 3: 462–463.
  • 9
    National Human Genome Research Institute. Genetic Information Nondiscrimination Act (GINA) of 2008. www.genome.gov/24519851.
  • 10
    Friedlander Y. Familial clustering of cornary heart disease: a review of its significance and role as a risk factor for the disease. In: GoldbourtU, de FaireU, BergK, eds. Genetic Factors in Coronary Heart Disease. Hingham, MA: Kluwer Academic Publishers; 1994; 37–53.
  • 11
    Hamsten A, de Faire U. Risk factors for coronary artery disease in families of young men with myocardial infarction. Am J Cardiol 1987; 59: 14–19.
  • 12
    Rissanen AM. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 1979; 44: 60–66.
  • 13
    Friedlander Y, Lev-Merom D, Kark JD. Family history as predictor of incidence of acute myocardial infarction: The Jerusalem Lipid Research Clinic. Presented at the 2nd International Conference on Preventive Cardiology and the 29th Annual Meeting of the AHA Council on Epidemiology, Washington, DC USA June 18–22, 1989.
  • 14
    AHA Heart Disease and Stroke Statistics 2005; Update. www. americanheart.org.
  • 15
    Sholtz RI, Rosenman RH, Brand RJ. The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study. Am J Epidemiol 1975; 102: 350–356.
  • 16
    Colditz GA, Rimm EB, Giovannucci E, et al. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 1991; 67: 933–938.
  • 17
    Barrett-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984; 69: 1065–1069.
  • 18
    Colditz GA, Stampfer MJ, Willett WC, et al. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986; 123: 48–58.
  • 19
    Schildkraut JM, Myers RH, Cupples LA, et al. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol 1989; 64: 555–559.
  • 20
    Marenberg ME, Risch N, Berkman LF, et al. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041–1046.
  • 21
    Rissanen AM. Familial occurrence of coronary heart disease: effect of age at diagnosis. Am J Cardiol 1979; 44: 60–66.
  • 22
    Taylor AJ, Bindeman J, Bhattarai S, et al. Subclinical calcified atherosclerosis in men and its association with a family history of premature coronary heart disease in first- and second-degree relatives. Prev Cardiol 2004; 7: 163–167.
    Direct Link:
  • 23
    Nasir K, Michos ED, Rumberger JA, et al. Coronary artery calcification and family history of premature coronary heart disease. sibling history is more strongly associated than parental history. Circulation 2004; 110: 2150–2156.
  • 24
    Anderson JL, Carlquist JF, Horne BD, et al. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Curr Atheroscler Rep 2007; 9: 179–186.
  • 25
    Superko HR. Did grandma give you heart disease? The new battle against coronary artery disease. Am J Card 1998; 82: 34–46.
  • 26
    Genest JJ, Martin-Munley SS, McNamara JR, et al. Familial lipoprotein disorders in patients with premature CAD. Circ 1992; 85: 2025–2033.
  • 27
    Roberts R, Stewart AF. Personalized genomic medicine: a future prerequisite for the prevention of coronary artery disease. Am Heart Hosp J 2006; 4: 222–227.
    Direct Link:
  • 28
    International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299–1320.
  • 29
    Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 1491–1493.
  • 30
    Wellcome Trust Case Control Consortium. Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 2007; 447: 661–678.
  • 31
    Samani NJ, Erdmann J, Hall AS. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443–453.
  • 32
    Broadbent HM, Peden JF, Lorkowski S, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008; 17: 806–814.
  • 33
    Superko HR. Lipid altering drugs LDL/HDL subclass distribution. match the treatment to the disorder. ACC Curr J Rev 2000; 9(3): 18–24.
  • 34
    Krauss RM. Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. In: SimopoulosAP, ed. Genetic Variation and Dietary Response. World Rev Nutr Diet. Basel, Karger 1997; 80: 22–43.
  • 35
    Williams PT, Krauss RM, Vranizan KM, et al. Effects of exercise induced weight loss on low density lipoprotein subfractions in healthy men. Arteriosclerosis 1989; 9: 623–632.
  • 36
    Superko HR, McGovern ME, Raul E, et al. Nicotinic acid has a differential effect on low density lipoprotein subclass distribution in patients classified as LDL pattern A, B, or I. Am J Card 2004; 94: 588–594.
  • 37
    Superko HR, Berneis KK, Williams PT, et al. Differential effect of gemfibrozil in normolipemic subjects with predominantly dense or buoyant low density lipoprotein particles and the effect on postprandial lipemia and Lp(a). Am J Cardiology 2005; 96: 1266–1272.
  • 38
    Weisgraber KH, Rall SC, Mahley RW. Human E apoprotein heterogeneity. J Biol Chem 1981; 256: 9077–9081.
  • 39
    Lopez-Miranda J, Ordovas JM, Mata P, et al. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994; 35: 1965–1975.
  • 40
    Loktionov A, Scollen S, McKeown N, et al. Gene-nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E epsilon4-carrying free-living individuals. Br J Nutr 2000; 84(6): 885–890.
  • 41
    Zambon A, Hokanson JE, Brown BG, et al. Evidence for a new pathophysiological mechanism for coronary artery disease regression. Circulation 1999; 99: 1959–1964.
  • 42
    Iakoubova OA, Tong CH, Rowland CM, et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol 2008; 51: 435–443.
  • 43
    Iakoubova OA, Sabatine MS, Rowland CM, et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2008; 51: 449–455.
  • 44
    Shiffman D, Chasman DI, Zee RY, et al. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. J Am Coll Cardiol 2008; 51(4): 444–448.
  • 45
    Centers for Disease Control and Prevention. Genomics Translation. www.cdc.gov/genomics/public/famhist.htm.
  • 46
    US Department of Health and Human Services. Surgeon Gerneral's Family Health History Initiative. www.hhs.gov/familyhistory/.
View Full Article (HTML) Get PDF (129K)